Director, New Product Commercialization

Who We Are:

At Neurocrine Biosciences, we pride ourselves on having a strong, inclusive, and positive culture based on our shared purpose and values. We know what it takes to be great, and we are as passionate about our people as we are about our purpose - to relieve suffering for people with great needs.

What We Do:

Neurocrine Biosciences is a leading neuroscience-focused, biopharmaceutical company with a simple purpose: to relieve suffering for people with great needs. We are dedicated to discovering and developing life-changing treatments for patients with under-addressed neurological, neuroendocrine and neuropsychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia, endometriosis* and uterine fibroids,* as well as a robust pipeline including multiple compounds in mid- to late-phase clinical development across our core therapeutic areas. For three decades, we have applied our unique insight into neuroscience and the interconnections between brain and body systems to treat complex conditions. We relentlessly pursue medicines to ease the burden of debilitating diseases and disorders because you deserve brave science. For more information, visit neurocrine.com, and follow the company on LinkedIn, X and Facebook. (*in collaboration with AbbVie)

About the Role:

The Director, New Product Commercialization is responsible for commercial input into lifecycle strategy, business development, as well as product and portfolio assessments across small-molecules, gene therapies, peptides and antibodies in one of four therapeutic areas: Neurology, Neuroimmunology, Neuroendocrinology or Psychiatry. Responsibilities include active participation in early commercial planning and market research for Neurocrine's therapeutic candidates from early-stage pre-clinical development through early phase three. Key workstreams include market opportunity assessments, patient journey and lifecycle prioritization for current and potential pipeline programs with emphasis on disease area understanding, competitive landscapes, unmet medical need, reimbursement environment and overall commercial attractiveness. This individual will lead commercial insights for development programs across stage gates in the drug development process.

_

Your Contributions (include, but are not limited to):

• Plans and conducts market research and analyses to maximize the value of product candidates and research programs in existing and new therapeutic areas

• Defines Target Product Profiles (TPPs) for cross-functional R&D teams developing novel therapeutic candidates to help inform asset opportunities

• Works in conjunction with Clinical Development and Medical Affairs, to identify and gain insights from scientific thought leaders as needed to inform clinical and commercial development plans

• Supports Business Development activities, including commercial due diligence on licensing, acquisition and collaboration opportunities

• Participates in the development of revenue forecasts and risk-adjusted net present value (NPV) models for all portfolio compounds in collaboration with key business partners (Finance, Clinical Development, etc.)

• Partners with cross-functional colleagues to help support lifecycle management (LCM) activities and decision-making

• Provides customer insights and recommendations